Some GLP-1 receptor agonists, particularly semaglutide, reduced the risk for worsening mental health in people with anxiety ...

There’s growing evidence that GLP-1 drugs can treat more than diabetes and obesity. “It was a surprise to people. Here’s an ...

Yale researchers study GLP-1’s potential to reduce addiction and improve outcomes in substance use disorder patients, based on clinical and ...

An eye-opening study from the VA Saint Louis Healthcare System shows what quitting weight-loss drugs can do to the heart.

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

By now you’ve heard plenty of buzz about GLP-1 medications like Ozempic, Wegovy and Zepbound. Originally developed for type 2 ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

Medically reviewed by Elizabeth Barnes, RDN Key Takeaways GLP-1 drug use was associated with slightly higher risks of bone ...